Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
Reported two positive readouts for rademikibart, the Company’s lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma […]
Reported two positive readouts for rademikibart, the Company’s lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma […]
BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class […]
DURHAM, N.C., April 16, 2024 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX) today announced that on April 10, 2024, the Compensation Committee […]
AUSTIN, Texas, April 16, 2024 (GLOBE NEWSWIRE) — Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or “the Company”), an industry […]
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell […]
EL SEGUNDO, Calif., April 16, 2024 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated […]
BOSTON, April 16, 2024 (GLOBE NEWSWIRE) — Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, […]
JACKSONVILLE, Fla., April 16, 2024 (GLOBE NEWSWIRE) — CSX (NASDAQ: CSX) has unveiled its first hydrogen-powered locomotive, marking a significant […]
EVANSVILLE, Ind., April 16, 2024 (GLOBE NEWSWIRE) — Old National Bancorp (“Old National” or the “Company”) has released its 2023 […]
HUNTINGTON BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced that it will release […]